ER stress signaling in ARPE-19 cells after inhibition of protein kinase CK2 by CX-4945

Cellular Signalling

Volumn 26, Issue 7, 2014, Pages 1567-1575

  Intemann, Johanna ^a   Saidu, Nathaniel Edward Bennett ^a   Schwind, Lisa ^a   Montenarh, Mathias ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Apoptosis; CHOP; ER stress; Growth arrest; Protein kinase

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CASEIN KINASE II; CX 4945; DIMETHYL SULFOXIDE; FLUOROURACIL; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INITIATION FACTOR 2ALPHA; PROTEIN SERINE THREONINE KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; TUNICAMYCIN; UNCLASSIFIED DRUG; 5-(3-CHLOROPHENYLAMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID; ATF4 PROTEIN, HUMAN; DDIT3 PROTEIN, HUMAN; INITIATION FACTOR 2; NAPHTHYRIDINE DERIVATIVE;

APOPTOSIS; ARPE 19 CELL; ARTICLE; CELL LINE; CELL STRAIN HCT116; CONTROLLED STUDY; DRUG STRUCTURE; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; G1 PHASE CELL CYCLE CHECKPOINT; HCT116 CELL LINE; METABOLISM; PHOSPHORYLATION; PROTEIN SYNTHESIS; TUMOR CELL LINE;

ACTIVATING TRANSCRIPTION FACTOR 4; APOPTOSIS; CASEIN KINASE II; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENDOPLASMIC RETICULUM STRESS; EUKARYOTIC INITIATION FACTOR-2; G1 PHASE CELL CYCLE CHECKPOINTS; HCT116 CELLS; HUMANS; NAPHTHYRIDINES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR CHOP;

EID: 84898631116     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.03.014     Document Type: Article

References (32)

1. Cao S.S., Kaufman R.J. Curr. Biol. 2012, 22:R622-R626.
2. Schroder M., Kaufman R.J. Annu. Rev. Biochem. 2005, 74:739-789.
3. Glembotski C.C. Circ. Res. 2007, 101:975-984.
4. Thuerauf D.J., Marcinko M., Gude N., Rubio M., Sussman M.A., Glembotski C.C. Circ. Res. 2006, 99:275-282.
5. Doh S.H., Kim J.H., Lee K.M., Park H.Y., Park C.K. Brain Res. 2010, 1308:158-166.
6. Schönthal A.H. Biochem. Pharmacol. 2013, 85:653-666.
7. Nawrocki S.T., Carew J.S., Dunner K., Boise L.H., Chiao P.J., Huang P., Abbruzzese J.L., McConkey D.J. Cancer Res. 2005, 65:11510-11519.
8. St-Denis N.A., Litchfield D.W. Cell. Mol. Life Sci. 2009, 66:1817-1829.
9. Pinna L.A., Meggio F. Prog. Cell Cycle Res. 1997, 3:77-97.
10. Ahmad K.A., Wang G., Slaton J., Unger G., Ahmed K. Anticancer Drugs 2005, 16:1037-1043.
11. Pierre F., Chua P.C., O'Brien S.E., Siddiqui-Jain A., Bourbon P., Haddach M., Michaux J., Nagasawa J., Schwaebe M.K., Stefan E., Vialettes A., Whitten J.P., Chen T.K., Darjania L., Stansfield R., Bliesath J., Drygin D., Ho C., Omori M., Proffitt C., Streiner N., Rice W.G., Ryckman D.M., Anderes K. Mol. Cell Biochem. 2011, 356:37-43.
12. Martins L.R., Lucio P., Melao A., Antunes I., Cardoso B.A., Stansfield R., Bertilaccio M.T., Ghia P., Drygin D., Silva M.G., Barata J.T. Leukemia 2014, 28:179-182.
13. Siddiqui-Jain A., Drygin D., Streiner N., Chua P., Pierre F., O'Brien S.E., Bliesath J., Omori M., Huser N., Ho C., Proffitt C., Schwaebe M.K., Ryckman D.M., Rice W.G., Anderes K. Cancer Res. 2010, 70:10288-10298.
14. Götz C., Montenarh M. Adv. Biol. Chem. 2013, 3A:1-5.
15. Strauss O. Physiol. Rev. 2005, 85:845-881.
16. Dunn K.C., Aotaki-Keen A.E., Putkey F.R., Hjelmeland L.M. Exp. Eye Res. 1996, 62:155-169.
17. Horoszewicz J.S., Leong S.S., Kawinski E., Karr J.P., Rosenthal H., Chu T.M., Mirand E.A., Murphy G.P. Cancer Res. 1983, 43:1809-1818.
18. Ahmad K.A., Wang G., Ahmed K. Mol. Cancer Res. 2006, 4:331-338.
19. Kim G.S., Jung J.E., Niizuma K., Chan P.H. J. Neurosci. 2009, 29:14779-14789.
20. Faust M., Jung M., Günther J., Zimmermann R., Montenarh M. Mol. Cell. Biochem. 2001, 227:73-80.
21. Ampofo E., Welker S., Jung M., Müller L., Greiner M., Zimmermann R., Montenarh M. Biochim. Biophys. Acta 2013, 1830:2938-2945.
22. Götz C., Müller A., Montenarh M., Zimmermann R., Dudek J. Biochem. Biophys. Res. Commun. 2009, 388:637-642.
23. Schneider C.C., Ampofo E., Montenarh M. Cell. Signal. 2012, 24:1797-1802.
24. Ubeda M., Habener J.F. J. Biol. Chem. 2003, 278:40514-40520.
25. Oyadomari S., Mori M. Cell Death Differ. 2004, 11:381-389.
26. Maytin E.V., Ubeda M., Lin J.C., Habener J.F. Exp. Cell Res. 2001, 267:193-204.
27. Hessenauer A., Schneider C.C., Götz C., Montenarh M. Cell. Signal. 2011, 23:145-151.
28. Ampofo E., Sokolowsky T., Götz C., Montenarh M. Biochim. Biophys. Acta Mol. Cell Res. 2013, 1833:439-451.
29. Trembley J.H., Wang G., Unger G., Slaton J., Ahmed K. Cell. Mol. Life Sci. 2009, 66:1858-1867.
30. Kim J., Kim S.H. Arch. Pharm. Res. 2012, 35:1293-1296.
31. Manni S., Brancalion A., Quotti T.L., Colpo A., Pavan L., Cabrelle A., Ave E., Zaffino F., Di M.G., Ruzzene M., Adami F., Zambello R., Pitari M.R., Tassone P., Pinna L.A., Gurrieri C., Semenzato G., Piazza F. Clin. Cancer Res. 2012, 18:1888-1900.
32. Ron D., Habener J.F. Genes Dev. 1992, 6:439-453.